Menu
ETF
Annual · values202520242023202220212020201920182017201620152014
Operating Cash Flow96.68 M USD638.26 M USD511.68 M USD342.81 M USD652.14 M USD437.14 M USD437.07 M USD435.09 M USD426.30 M USD410.59 M USD303.45 M USD290.24 M USD
Depreciation & Amortization177.74 M USD274.60 M USD242.12 M USD230.59 M USD237.36 M USD227.25 M USD218.37 M USD214.71 M USD160.34 M USD128.35 M USD125.33 M USD127.03 M USD
Stock-Based Compensation25.70 M USD31.35 M USD31.46 M USD27.22 M USD22.94 M USD20.74 M USD26.94 M USD22.44 M USD19.41 M USD16.87 M USD14.47 M USD12.23 M USD
Capital Expenditures95.24 M USD126.43 M USD91.44 M USD79.19 M USD71.62 M USD90.69 M USD102.69 M USD80.80 M USD70.90 M USD53.13 M USD61.45 M USD67.57 M USD
Cash Flow from Investing-812.65 M USD-99.36 M USD-621.23 M USD-259.41 M USD156.74 M USD-837.78 M USD-73.48 M USD-196.39 M USD-1.83 B USD-56.97 M USD-154.85 M USD-108.14 M USD
Cash Flow from Financing611.54 M USD-421.93 M USD38.54 M USD-217.51 M USD-715.82 M USD455.16 M USD-418.84 M USD-206.43 M USD1.14 B USD-118.69 M USD-85.58 M USD-287.70 M USD
Dividends Paid60.27 M USD63.54 M USD63.90 M USD63.79 M USD63.65 M USD63.22 M USD62.83 M USD62.16 M USD61.24 M USD58.96 M USD56.53 M USD56.26 M USD
Stock Buybacks300.00 M USD200.00 M USD0 USD0 USD
Free Cash Flow1.45 M USD511.83 M USD420.24 M USD263.62 M USD580.52 M USD346.45 M USD334.37 M USD354.29 M USD355.40 M USD357.45 M USD242.00 M USD222.67 M USD

Teleflex Incorporated is a global leader in the development, manufacturing, and distribution of single-use medical devices, with its headquarters in Wayne, Pennsylvania. The company's core mission is to improve patient health and quality of life by providing innovative medical technologies designed for procedures in critical care and surgery. Teleflex’s diverse product range serves key areas such as vascular and interventional access, anesthesia, cardiac care, surgical procedures, urology, emergency medicine, and respiratory care. Its portfolio includes well-recognized brands like Arrow, Deknatel, LMA, Pilling, QuikClot, Rüsch, UroLift System, and Weck. A significant portion of Teleflex's sales comes from interventional cardiology, radiology, urology, vascular access, and anesthesia products. With operations spanning over 40 countries and a workforce exceeding 14,000 employees, Teleflex plays a vital role in the global healthcare sector by supporting hospitals and healthcare professionals with clinically significant, high-quality solutions for complex medical needs.